CIBC World Market’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,965
Closed -$983K – 1628
2026
Q2
$983K Buy
3,965
+601
+18% +$129K ﹤0.01% 1026
2026
Q1
$676K Buy
3,364
+235
+8% +$48.6K ﹤0.01% 1042
2025
Q4
$646K Buy
3,129
+294
+10% +$58.7K ﹤0.01% 1050
2025
Q3
$508K Buy
+2,835
New +$483K ﹤0.01% 1117
2018
Q3
– Sell
-6,647
Closed -$931K – 1157
2018
Q2
$931K Buy
+6,647
New +$913K ﹤0.01% 689
2017
Q3
– Sell
-5,896
Closed -$672K – 877
2017
Q2
$672K Buy
+5,896
New +$634K ﹤0.01% 750

Other funds holding FBT

CIBC World Market's FBT Position: Q3 2026 in Review

CIBC World Market sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 3,965 shares — an estimated $983K sold.

CIBC World Market first reported a position in FBT in Q2 2017 and held it in 6 quarters. The position peaked at $983K in Q2 2026. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • CIBC World Market reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
  • CIBC World Market sold 3,965 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $983K.
  • CIBC World Market first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and held it in 6 quarters.
  • CIBC World Market's First Trust NYSE Arca Biotechnology Index Fund position peaked at $983K in Q2 2026.
  • 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on CIBC World Market's 13F filing for Q3 2026, filed 10 Nov 2026.